Successful Share Placement AtCor Medical Holdings Limited...

Successful Share Placement AtCor Medical Holdings Limited (ASX:ACG), the developer and marketer of the SphygmoCor® systems which noninvasively measure central aortic blood pressures and arterial stiffness, announced today that it has successfully raised $1 million from institutional and sophisticated investors.
The issue price of $0.093 per share represents a 3% discount to the 10 days volume weighted average share price. A total 10,752,700 new shares will be issued bringing total shares on issue after the raising to 168,192,979.
The cornerstone investor in the placement is Oceania Capital Partners Limited, a listed investment company (ASX:OCP), which will hold approximately 5% of AtCor's issued capital following completion of the placement.
Oceania Capital Partners director, Michael Jacobson, commented:
“Having followed AtCor closely for over two years, we are pleased to make this investment which will facilitate AtCor's focus on its key growth initiatives.”
Duncan Ross, AtCor Medical CEO, said,
"We are delighted to welcome Oceania Capital Partners to our shareholder base; they are thoughtful investors that recognise the clear upside potential for AtCor.
This intentionally limited capital raise has been enhanced by the additional support from other sophisticated investors.”